News

An international consortium, which includes the Hübner and Ohler Labs, has reported in “Nature,” discovering more than 1,700 proteins that may be relevant in human diseases. Mostly very small, they were found in the “dark proteome,” a catalogue of gene products from overlooked sections of DNA.

In “Nature Communications,” Max Delbrück Center researchers show how immune cells initiate zebrafish heart regeneration, highlighting the possibility that precisely timed inflammatory signaling of specific immune cells — rather than broad suppression — could inform new approaches to cardiac repair.

The German Centre for Cardiovascular Research (DZHK) has elected a new executive board. Our Vice Director Holger Gerhardt will continue to serve as part of the three-member leadership team. Congratulations!

Researchers at the the Deutsches Herzzentrum der Charité and the Max Delbrück Center have identified a unique metabolic fingerprint in the hearts of patients with HFpEF and obesity. The findings, which were published in “Cardiovascular Research,” point to new drug targets.

The work of researchers is becoming more complex, but the way we evaluate it has not changed much. At the Max Delbrück Center, we have taken on a pioneering role in establishing new criteria. An interview with Chiara Giacomelli on transformation, collaboration, and why small steps matter.

In 2025, researchers at the Max Delbrück Center and its partner institutions used almost one-third fewer research animals than in the previous year – a total of 23,878. The center has submitted the figures to the Berlin State Office for Health and Social Affairs.

The Helmholtz Institute for Translational AngioCardioScience in Mannheim/Heidelberg has appointed vascular biologist Karina Yaniv from the Weizmann Institute as its new Scientific Director. Yaniv will bridge research across institutes to fast-track therapies for cardiovascular disease.

Families, researchers, and clinicians will gather in Berlin to share knowledge and build momentum toward therapies for NEDAMSS, a rare neurodevelopmental disorder. Jakob Metzger, Group Leader of the Quantitative Stem Cell Biology lab explains why this day matters and what participants can expect.

Joint press release by the Max Delbrück Center and the Helmholtz Centre for Infection Research One...

The founding director of the Max Delbrück Center, physician and pharmacologist Detlev Ganten, celebrates his 85th birthday on March 28, 2026. Without his commitment, our research center would not exist as we know it today. Once again, we say thank you and offer our heartfelt congratulations!